DR REDDY'S FORMULATIONS LIMITED
Location
Telangana
Founded
2021-03-11
Website
Risk Signals
2 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Chemicals and Chemical Preparations, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about DR REDDY'S FORMULATIONS LIMITED
Live alerts from global media, monitored by Business Radar
2023-06-05 (businesswire.com)
Dr. Reddy’s Successfully Completes Phase I Study (IV Route) of DRL_TC, a Proposed Biosimilar of Tocilizumab
Dr. Reddy’s announced that its tocilizumab biosimilar candidate, DRL_TC, successfully met its primary and secondary endpoints in a Phase I study.
Read more